156 related articles for article (PubMed ID: 1715225)
1. Perspectives in the prevention and treatment of acute graft versus host disease.
Herve P
Bone Marrow Transplant; 1991; 7 Suppl 2():117-9. PubMed ID: 1715225
[No Abstract] [Full Text] [Related]
2. Graft versus host disease prophylaxis today.
Martelli MF; Aversa F
Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
[No Abstract] [Full Text] [Related]
3. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
Hervé P; Racadot E; Wijdenes J; Flesch M; Tiberghien P; Bordigoni P; Holler E; Powles M; Bourdeau M; Wilmer E
Bone Marrow Transplant; 1991; 7 Suppl 2():149. PubMed ID: 1878688
[No Abstract] [Full Text] [Related]
5. Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
Antin JH; Bierer BE; Smith BR; Guinan EC; Provost MM; Ferrara J; Macklis RM; Tarbell NJ; Blythman H; Bouloux C
Prog Clin Biol Res; 1990; 333():207-15. PubMed ID: 1689852
[No Abstract] [Full Text] [Related]
6. Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor.
Tiley C; Powles R; Teo CP; Treleaven J; Findlay M; Hewetson M
Bone Marrow Transplant; 1991; 7 Suppl 2():151. PubMed ID: 1652326
[No Abstract] [Full Text] [Related]
7. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
8. Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT).
Blaise D; Guyotat D; Reiffers J; Olive D; Michallet M; Bellanger C; Vernant JP; Ifrah N; Attal M; Vilmer E
Bone Marrow Transplant; 1991; 7 Suppl 2():150. PubMed ID: 1878689
[No Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
10. [Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].
Iriondo A; Richard C; Hermosa V; Conde E; Garijo J; Cuadrado MA; Bello C; Muruzábal MJ; Pérez-Encinas M; Zubizarreta A
Med Clin (Barc); 1988 Oct; 91(13):488-92. PubMed ID: 3067007
[No Abstract] [Full Text] [Related]
11. Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.
Herbelin C; Stephan JL; Donadieu J; Le Deist F; Racadot E; Wijdenes J; Fischer A
Bone Marrow Transplant; 1994 May; 13(5):563-9. PubMed ID: 8054909
[TBL] [Abstract][Full Text] [Related]
12. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
[TBL] [Abstract][Full Text] [Related]
13. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
14. Prevention of graft-versus-host disease by using immunotoxins.
Laurent G; Bouloux C
Prog Clin Biol Res; 1992; 377():129-36; discussion 137. PubMed ID: 1438408
[No Abstract] [Full Text] [Related]
15. A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
Henslee PJ; Byers VS; Jennings CD; Marciniak E; Thompson JS; Macdonald JS; Romond EH; Messino MJ; Scannon PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3004-7. PubMed ID: 2650413
[No Abstract] [Full Text] [Related]
16. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
Holler E; Kolb HJ; Hintermeier-Knabe R; Mittermüller J; Thierfelder S; Kaul M; Wilmanns W
Transplant Proc; 1993 Feb; 25(1 Pt 2):1234-6. PubMed ID: 8442099
[No Abstract] [Full Text] [Related]
17. Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients.
Deeg HJ
Bone Marrow Transplant; 1994; 14 Suppl 4():S56-60. PubMed ID: 7728127
[TBL] [Abstract][Full Text] [Related]
18. T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead.
Prentice HG; Brenner MK; Gottlieb D
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():225-8. PubMed ID: 2653508
[No Abstract] [Full Text] [Related]
19. Graft versus host disease.
Gordon-Smith EC
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):413-9. PubMed ID: 2480283
[No Abstract] [Full Text] [Related]
20. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
de Witte T; Preijers F; Schattenberg A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
